
01 · Health
Start with your health
First, let's understand you.
Tell us about your health, medical history, current weight, and goals through a short online assessment.
No commitment to treatment.
Diwali offer — 30% off, just for you
A festive saving, yours till Diwali. Grab it before it’s gone.
Doctor-guided weight management
Backed by science. Guided by doctors.
Doctor-guided weight management, personalised to your health, with evidence-based treatment when appropriate and ongoing support.
Check my eligibilityStart with a simple online assessment. Treatment requires medical evaluation and a prescription when appropriate.
The science behind modern weight management
Decades of research into metabolism and GLP-1 biology have helped transform the treatment of obesity.
Harvard Medical School·The Rockefeller University·University of Toronto

GLP-1, in public conversation
What each person has actually said. A reported change in weight is their account, not a result Go Active can offer.

Elon Musk
Has publicly discussed using Wegovy and, later, Mounjaro.

Oprah Winfrey
Has spoken about using a prescription weight-loss medicine. She has not publicly named the drug.

Hansal Mehta
Has publicly discussed using Mounjaro, and said he was down nearly 10 kg in a few months.

Aishwarya Mohanraj
Has publicly discussed using Mounjaro, and said her weight went from 74 kg to 52 kg over six months.

Tanmay Bhat
Has publicly discussed experimenting with a GLP-1 medicine. He said an earlier loss of more than 75 kg was without one.

Ram Kapoor
Said he went from about 140 kg to 85 kg. He described two meals a day, one late in the morning and one in the early evening, with cardio and strength training.

Karan Johar
Described a clear change in his weight. He said that, after treatment for a thyroid condition, he ate one meal a day for about seven months, with no lactose, gluten, or sugar.

Badshah
Said he lost about 20 kg. He described smaller portions, more salads, and regular training, after finding he ran short of breath quickly on stage.

Jr NTR
Lost weight for a film role. His director has said he dropped about 15 kg over four months. His trainer described morning sessions built around cardio and functional work.
Public figures' experiences are personal and do not predict your results. None of these individuals endorses Go Active.
Use this as a starting point. It is not a diagnosis or a guarantee, but it can give you a clearer sense of a four-month illustration.

Before
91 kg
After
70 kg
-21 kg
Your journey with Go Active
Five clear steps. Professional guidance throughout. And a doctor who determines what is appropriate for your health.
An initial assessment is not a diagnosis or a guarantee of treatment.
The science behind the treatment
GLP-1-based medicines have been studied for their effects on appetite, blood sugar, cardiovascular outcomes, and other health conditions. What the evidence shows depends on the medicine, the population studied, and the outcome measured.

Helping regulate appetite.
Semaglutide acts on pathways involved in appetite regulation. In clinical trials, it helped participants reduce body weight when combined with lifestyle interventions.

Metabolic health matters, too.
GLP-1-based medicines can affect blood glucose regulation. Some are approved for type 2 diabetes, while specific medicines have separate indications for weight management.

Evidence beyond the scales.
In the SELECT trial, semaglutide 2.4 mg reduced major adverse cardiovascular events compared with placebo in adults with overweight or obesity, established cardiovascular disease, and no diabetes.

Weight management and sleep health.
The SURMOUNT-OSA trials found that tirzepatide reduced the severity of obstructive sleep apnea in adults with obesity and moderate-to-severe disease.
These findings relate to specific medicines and study populations. They do not establish that every treatment provides every benefit, or that the results will apply to you. A qualified clinician can assess which evidence is relevant to your circumstances.
Research sources: STEP 1, NEJM (2021) · SELECT, NEJM (2023) · SURMOUNT-OSA, NEJM (2024)
Customer stories
We have not published customer stories. We will only share one with the person’s written consent.
Questions
Not necessarily. A doctor decides whether medication is clinically appropriate.
No. It is a general illustration, not a personal weight prediction.
Yes. Your doctor should discuss the potential benefits, risks, and whether a medicine is suitable for you.
Tell your clinician. For chest pain, severe breathlessness, fainting, severe abdominal pain, or thoughts of harming yourself, call 112.
Yes. Weight can return after treatment stops. Do not stop a prescription without speaking to your clinician.
No. The form is a screening assessment, not a diagnosis.
No. Your health answers are not sent to analytics.
Share your health details to see whether a clinical review may be right for you.
The beginning of a fitter you
Start assessment